Annual financial news and ad hoc releases
In our archive you will find financial news since 2005
Frankfurt am Main, March 24, 2011 – The Management Board of MEDICLIN Aktiengesellschaft (MediClin) said at this year’s balance sheet press conference that he is satisfied with the results of the year 2010.
„We have reached our internal growth target of plus 3.0 % per year. Sales rose by 3.5 %, or by EUR 16.6 mill. as compared to the previous year up to EUR 487.2 mill. “, said Dr. Ulrich Wandschneider, CEO of MediClin. In the post-acute segment, sales increased by 1.9 %, from EUR 270.0 mill. to EUR 275.2 mill. In the acute segment, sales rose even stronger, namely by 5.6 % or EUR 10.7 mill. to EUR 200.3 mill.
The Management Board was also satisfied with the sales development of the outpatient services and the medical care centres. In 2010, sales from outpatient services rose by EUR 4.4 mill. to EUR 16.3 mill., which constitutes 3.3 % of the consolidated sales revenues. Of this sum, approximately EUR 6.9 mill. (2009: EUR 3.2 mill.) was attributable to the medical care centres.
The consolidated operating result did not rise. At EUR 16.9 mill., it is just under the 2009 result (2009: EUR 17.0 mill.). The result was primarily affected by higher maintenance costs as compared to the previous year, as well as higher personnel costs due to personnel recruitment. In terms of the segments, the post-acute segment result of EUR 6.2 mill. was on a par with the previous year. The acute segment result improved in relation to the previous year, totalling EUR 18.1 mill. The EBIT margins are 2.2 % and 9.1 %, respectively.
Proposal of a dividend payment
As business development in 2010 was satisfactory, and the Management Board foresee stable economic environment as well as a stable labour market in 2011, the Management Board and the Supervisory Board will propose a dividend of EUR 0.05 per share for the 2010 financial year at the Annual General Meeting on 26 May 2011.
Outlook
MediClin will again invest in internal growth in 2011, and, as long as framework conditions in the industry and the referral practices of coverage providers do not change drastically, the Management Board anticipates a slight increase in sales and a result on the previous year’s level.
Key figures - yoy comparison and quarterly development of the Group and the segments
About MediClin AG (Ticker: MED; ISIN: DE0006595101)
MediClin AG is a nation-wide clinic operator and large provider of services in the area of Psycho- and Neurosciences as well as Orthopaedic. With 34 clinics and 7 nursing care facilities and 11 Medizinische Versorgungszentren (medical care units) in 11 federal states MediClin has a total capacity of approximately 8,000 beds. MediClins’ facilities include acute care clinics, i.e., general hospitals, special treatment facilities, specialised hospitals and clinics for post-acute treatment and medical rehabilitation. MediClin has approximately 8,100 employees.
Important notice:
This press release includes future-oriented statements which are based on assumptions and estimates. While MediClin AG is of the opinion that these assumptions and estimates are correct, the actual future developments and actual future results may deviate from these assumptions and estimates due to the impact of various factors such as changes in the economic conditions in Germany, legal changes concerning the health system, changes relating to cost providers’ expense behaviour. MediClin does not assume liability and gives no warranty that future developments and the income actually achieved in the future will comply with the assumptions and estimates stated in this press release.